Global venture capital firm with a focus on early and growth-stage technology companies.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| TILT Biotherapeutics | 2025 | Series B | $25.3M | Helsinki |
| PhaseV | 2025 | Series A | $50.0M | Boston |
| Cerabyte | 2025 | Corporate Round | Undisclosed | Munich |
| Alta Ares | 2025 | Pre-Seed | $2.2M | Romainville |
| Markopolo AI | 2025 | Seed | $2.0M | Sheridan |
| Axe | 2025 | Pre-Seed | $1.7M | London |
| Vaya | 2025 | Seed | $1.5M | New Delhi |
| Avalon Holographics | 2025 | Series C | $14.4M | St. John's |
| NextGen Jane | 2025 | Grant | $2.2M | Oakland |
| Calyx | 2025 | Grant | $10K | Berkeley |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1001 | TILT Biotherapeutics | Series B | $25.3M | Helsinki, Finland |
| 1002 | PhaseV | Series A | $50.0M | Boston, United States |
| 1003 | Cerabyte | Corporate Round | Undisclosed | Munich, Germany |
| 1004 | Alta Ares | Pre-Seed | $2.2M | Romainville, France |
| 1005 | Markopolo AI | Seed | $2.0M | Sheridan, United States |
| 1006 | Axe | Pre-Seed | $1.7M | London, United Kingdom |
| 1007 | Vaya | Seed | $1.5M | New Delhi, India |
| 1008 | Avalon Holographics | Series C | $14.4M | St. John's, Canada |
| 1009 | NextGen Jane | Grant | $2.2M | Oakland, United States |
| 1010 | Calyx | Grant | $10K | Berkeley, United States |
TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor.
PhaseV provides AI-driven solutions for efficient clinical development and operations.
Cerabyte develops a ceramic-based data storage technology, offering a unique solution for data preservation.
Alta Ares is a data integration surveillance service provider that utilizes drone imaging.
Markopolo is an AI-driven customer engagement platform that helps e-commerce businesses recover lost revenue.
Axe is a software firm that develops procurement software for businesses.
Vaya is a Vedic astrology startup powered by artificial intelligence.
Avalon Holographics designs holographic displays for commercial and consumer applications.
NextGen Jane is a data-driven women's health company.
Calyx harnesses AI computer vision to provide highly accurate and scalable sensors for real-time monitoring and analysis in poultry.
Pulse Charter Connect provides organ transportation logistics services.
Posha builds cooking robots for domestic households to help them put home-cooking on auto-pilot.
Denovo Sciences is a technology company that creates novel therapeutics using state of the-art AI technologies.
Recraft is a generative AI design platform that enables designers to create and edit vector art, illustrations, icons, and 3D graphics.
Nqoodlet is a fintech company that develops an expense management platform for small and medium-sized enterprises to manage their spending.
OSCAR is a home services app that offers a platform for booking various on-demand home services for customers.
OncoSwab is creating a point-of-care test to detect lung cancer in high-risk individuals.
Catalyxx Inc focuses on sustainable chemical processes using thermo-chemical catalytic technology.
Solda.AI builds brand-custom, multilingual AI voice agents for banks and fintechs.
Otherwise Brewing is a San Francisco's first gluten free craft brewery producing flavorful free beers for all drinkers.
True Anomaly is builds space security and resilience at the intersection of spacecraft, software, and autonomy.
Cohesity is a data management technology firm that offers hyper-converged secondary storage solutions for backups, files, and analytics.
Scandalous Foods offers food preparation services such as 6-month preservative-free sweets in single-serve sizes.
PAWCHI is a pet insurance company.
Lightrun provides real-time application insights and dynamic instrumentation for developers.
Accel has invested in 3,802 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Accel's top investment sectors include Artificial Intelligence (AI), Biotechnology, Health Care, Information Technology, Manufacturing. The firm invests across 62 different industry categories.
Among tracked funding rounds, True Anomaly received $260.0M in a Series C round. Accel's total known invested capital is $81.8B.
Accel's average investment size is $178.1M across its portfolio of 3,802 companies.
Recent Accel portfolio additions include TILT Biotherapeutics, PhaseV, Cerabyte, Alta Ares, Markopolo AI. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors